The role of aldosterone and its part in cardiorenal disease

19 May 2025 (12:38 - 12:53)

Organised by:

Slides

Sign in for access options

About the speaker

Doctor Maria Rosa Costanzo

Midwest Cardiovascular Institute, Naperville (United States of America)

6 More presentations in this session

Presentation thumbnail

Welcome and introductions

Presentation thumbnail

The integrated nature of cardiorenal metabolic health

Professor L. Lund (Stockholm, SE)

Presentation thumbnail

Insights from the vicadrostat phase 2 study and implications for further clinical development

Doctor R. Mentz (Durham, US)

Presentation thumbnail

Aldosterone synthase inhibition and the future CRM treatment landscape

Professor J. Butler (Dallas, US)

Presentation thumbnail

Outlook, panel discussion and Q&A

Access the full session

Session thumbnail

Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?

The Event

Event poster

Heart Failure 2025

19 May 2025 12:38 CET

You may be interested in

Webinar

Nonsteroidal MRAs and heart failure: interpretation and impact on practice - which patients should be receiving MRAs?

21 July 2025

Congress Presentation

A safety and pharmacodynamic study of the highly selective aldosterone synthase inhibitor PB6440 in the cynomolgus monkey

26 August 2022

Congress Presentation

High prevalence of aldosterone dysregulation in hypertensive adults tested for aldosterone and renin levels

1 September 2025

Congress Presentation

Role of aldosterone in long-term left ventricular remodelling after acute myocardial infarction: the REMI study

22 May 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources